Click on the thumbnails below to read more about our faculty members
Dr Barron is the Senior Cardiac Surgeon at Birmingham Children’s Hospital, UK. He was trained at St Thomas’ Hospital London and his cardiothoracic training was at Papworth, Southampton, Royal Brompton and Great Ormond Street. His MD was from Imperial College , London.
He has been a consultant surgeon in Birmingham since 1999 where his special interests are Hypoplastic Left Heart Syndrome, congenitally corrected transposition and MAPCA surgery in complex pulmonary atresia. He has published over 120 papers on surgical topics as well as in developing risk adjustment scores and national database development in congenital cardiac surgery. He has been honorary invited surgeon to 11 different hospitals in 6 countries. He has written 14 book chapters and has delivered over 100 invited national and international lectures.
He was the inaugural chair of the UK congenital heart surgeons body and has been the national representative in the NHS review of congenital cardiac services. He has sat on the executive of both the Society of Cardiothoracic Surgeons of Great Britain and the British Congenital Cardiac Association and is the lead for Congenital Cardiac training in the UK. He is also on the congenital domain of the European Association and is on the Editorial Board of the European and World Journals. A lifelong Newcastle United fan, his loyalty has taught him how to cope with disappointment.
Dr. Baruah is currently a consultant cardiologist working at Chelsea and Westminster and the Royal Brompton and Harefield NHS Trusts with a specialist interest in heart failure and imaging.
She graduated from Imperial College with Distinction in clinical practice, and a first class honours BSc in cardiovascular sciences. She completed her PhD in periodic breathing and heart failure at Imperial College in 2010.
She is currently undertaking an MSc in Health economics, outcomes and management in cardiovascular sciences at the London School of Economics, which supports her work at the National Institute of Clinical Excellence (NICE) where she has just been a specialist technical advisor on the 2018 chronic heart failure guideline update.
She is a mother to two boisterous young boys and in her spare time she volunteers as a school governor at a local secondary school.
Jeroen J. Bax is Professor of Cardiology and Director of non-invasive cardiac imaging, at the Department of Cardiology, Leiden University Medical Center, The Netherlands. He has been working intensively with the European Society of Cardiology (ESC) and is currently serving as President of the ESC. He has been Associate Editor of the American College of Cardiology and is currently Associate Editor of the European Heart Journal. He has co-authored numerous scientific articles, has guided many PhD fellows and his main interests of research include imaging in heart failure, stable coronary artery disease, valvular heart disease and atrial fibrillation.
Ralf Birkemeyer is an interventional cardiologist at the Herzklinik Ulm and Universitätsklinik Ulm, Germany.
Dr. Birkemeyer graduated from medical school at Justus-Liebig-University Gießen. He completed a two-year research scholarship as an undergraduate which was funded by the German Scholarship Foundation.
After specialist training in internal medicine, cardiology and intensive care medicine he became deputy head of cardiology at the Schwarzwald Baar Klinikum, where he set up a comprehensive interventional service and regional primary PCI network.
In 2011 he joined the structural heart team at the University Hospital of Rostock. In 2014 he became partner at the Herzklinik Ulm and joined the structural heart team at the University Hospital of Ulm where he is also an Associate Professor of Cardiology.
His main research interests are primary PCI and coronary device development. Dr. Birkemeyer has been involved in more than 40 cardiology trials and has published more than 60 peer-reviewed manuscripts and book chapters. He is a member of several professional associations, including the European Society of Cardiology (ESC), Association for Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology, German Cardiac Society (DGK) and the Working Group Interventional Cardiology (AGIK) of the German Cardiac Society.
Dr Michael Böhm performed his medical training at the Medical School of Hannover in Germany. Residency in Internal Medicine and fellowships in Cardiology at the Ludwig Maximilians-Unversity in Munich/Germany at the Klinikum Großhadern; Heisenberg Graduate of the Deutsche Forschungsgemeinschaft; Assistant and Associate Dr of Internal Medicine and Cardiology at the Universität zu Köln in Germany.
Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the University of the Saarland in Homburg/Saar in Germany. Dr Böhm's special interest includes pathophysiology and therapy of heart failure. Particular, he is involved in studies on signal transduction in the failing heart and in vascular biology. Dr Böhm has been the principal investigator in several international multicenter studies. He has written more than 350 original papers, book chapters and review articles. He has obtained several awards of scientific societies. Dr Böhm is a reviewer for most recognized scientific journals in the cardiovascular field and chief editor Clinical Research in Cardiology. He is president of the German Society of Cardiology.
Professor Bolotin received his MD in 1993 from the Hebrew University ‐ Hadassah Medical School in Jerusalem, Israel; and his PhD. in 2001 from Academic Hospital Maastricht, The Netherlands. He performed his residency in the Department of Cardio-Thoracic Surgery at Carmel Medical Center, Haifa, Israel. In 2007, he was appointed Director of the Department of Cardiac Surgery, Rambam Medical Center. In 2015, he was appointed Clinical Associate Professor at the Ruth & Bruce Rappaport Faculty of Medicine, Technion Institute of Technology (Technion), Haifa, Israel.
In addition, Professor Bolotin was the Chairman of the Israel Society of Cardiothoracic Surgery (2014-2017) and is a member of international professional cardiothoracic societies - European Society of Cardiothoracic Surgery and World Society of Cardiothoracic Surgeons.
Professor Bolotin has published over 100 publications in peer‐review journals and book chapters and presented at numerous international professional meetings. He also has extensive teaching experience in national and international cardiothoracic surgery courses.
From the onset of his medical career, Professor Bolotin was deeply interested in medical devices from engineering design through in vitro, in vivo and clinical studies. His research interests have since expanded to span the entire range of cardiothoracic surgery, with a special interest in minimally invasive valve surgery, transcatheter valve implantation, atrial fibrillation, robotic cardiac surgery and other innovations in cardiac surgery.
Andrew Chapman is a Cardiologist training in Scotland and an Honorary Clinical Research Fellow at the University of Edinburgh.
He recently completed a three year PhD fellowship funded by the British Heart Foundation into the use of high-sensitivity cardiac troponin for risk stratification in patients with the suspected acute coronary syndrome. His research has been published extensively and has been recognized by national and international awards, including the Samuel A. Levine Young Investigator Award by the American Heart Association in 2017.
Working with Professor Nicholas Mills and Professor David Newby, Andrew helped to deliver the High-STEACS randomized controlled trial, evaluating the implementation of a high-sensitivity cardiac troponin assay in 50,000 consecutive patients in Scotland, which will be presented as a Late-Breaking Clinical Trial at the European Society of Cardiology Congress in Munich later this year. He is leading a further randomized trial evaluating the use of an early rule out the pathway in 30,000 Emergency Department patients with the suspected acute coronary syndrome, which is due to report in early 2019.
Andrew’s main research interests are into the mechanisms of myocardial injury in patients with type 2 myocardial infarction, and he is leading a clinical trial addressing this question using both invasive and non-invasive imaging. When he has completed his training, Andrew hopes to work as an academic cardiologist in Scotland.
Graeme Codrington is an expert on the future of work. He is a researcher, author, futurist, presenter and board advisor working across multiple industries and sectors. He has a particular interest in disruptive forces changing how people live, work, interact and connect with each other.
Speaking internationally to over 100,000 people in more than 20 different countries every year, his client list includes some of the world’s top companies, and CEOs invite him back time after time to share his latest insights and help them and their teams gain a clear understanding of how to successfully prepare for the future. Graeme is the co-founder and international director of TomorrowToday, a global firm of futurists and business strategists. He is also a guest lecturer at five top business schools, including the London Business School, Duke Corporate Education and the Gordon Institute of Business Science. He has five degrees, including a Doctorate in Business Administration (DBA), a Masters in Sociology, and other professional degrees in Accounting, Arts and Theology, and Youth Work.
Graeme is the only speaker in the world to have been admitted to two different speakers halls of fame, in both South Africa and the UK (where he was awarded the Professional Speaking Association’s Award of Excellence). He is one of only a handful of professional speakers in the world to have earned the Global Certified Speaking Professional status from the Global Speakers Federation.
He has written five books, including the award winning, “Mind the Gap” and “Future-Proof Your Child”, published by Penguin. His latest book is “Leading in a Changing World”, published in July 2015. Graeme writes regularly for numerous blogs, magazines and journals, and is regularly called upon for comment by the media around the world.
Graeme’s breadth of knowledge and expertise make him highly relevant in today’s rapidly evolving business world. Along with his formal qualifications and research credentials, he has a wide range of business experience. He did Chartered Accountancy articles at KPMG, was involved in an IT startup, worked in the Charity sector, has been a professional musician, a strategy consultant and is now a full-time speaker, facilitator and author.
Professor Marc Gewillig is Paediatric cardiologist at the University of Leuven, Belgium.
He is an author of more than 320 articles in peer-reviewed journals and wrote several chapters on paediatric cardiology. He has been invited a speaker on several topics in all continents.
Since his thesis on the Fontan circulation in 1991, he maintained a special interest in the physiology and treatment of complications of this complex circuit. He was a co-founder of the European Working group on Interventional Cardiology (AEPC) and is currently proctor/instructor in Europe.
Ian Graham is Professor of Cardiovascular Medicine in Trinity College, Dublin, and Professor Emeritus of Preventive Cardiology at the Royal College of Surgeons in Ireland. He is Secretary-Treasurer and Board Member of the European Society of Cardiology and Chairman of the Adelaide Health Foundation Health Policy Initiative. He is a member of the 6th Joint European Societies Task Force on the Prevention of Cardiovascular Disease in clinical practice and of its Prevention Implementation Committee, having Chaired the 4th Task Force. He is co-Chair of the 2016 European Guidelines on the management of dyslipidaemias, and co-Chair of an expert group that is advising the World Health Organisation on cardiovascular risk estimation.
Professor Graham studied medicine at Trinity College in Dublin and worked in Dublin and Cambridge before becoming Head of Cardiology at Tallaght Hospital in Dublin and Vice-Chair of its Board of management. He was Director of Research at St Vincent’s Hospital in Dublin and at the Irish Heart Foundation. He is past President of the Irish Heart Foundation, the Dublin University Biological Association and the Irish Hyperlipidaemia Association. He founded the Irish National Cardiac Surgery register.
He is an honorary Fellow of Trinity College in Dublin, a Fellow of the Royal College of Physicians and a Fellow of the Royal Academy of Medicine in Ireland. He is a recipient of the Stokes Medal of the Irish Cardiac Society, and Sir Thomas and Lady Dixon Medal from the Royal Victoria Hospital in Belfast. He held a Medical Research Council Fellowship, an EU travelling Fellowship at Erasmus University in Rotterdam and an ISFC Cardiovascular Epidemiology Fellowship.
Research interests include the natural history of coronary heart disease, cardiovascular risk estimation, blood lipids, health policy and planning and the evaluation of therapies. He has written extensively in these areas.
Professor Ganesan Karthikeyan is a clinical and interventional cardiologist and a Professor of Cardiology at the All India Institute of Medical Sciences, New Delhi in India where he completed his training in Cardiology. He trained in research methods at McMaster University, Canada, as a recipient of the CIHR-Canada HOPE Scholarship. He was an Honorary Visiting Professor of Medicine and is now an International Fellow of the Population Health Research Institute, at that University.
His research is mainly focused on cardiovascular diseases affecting low and middle-income countries, including valvular heart disease, particularly rheumatic heart disease (RHD).
Dr Karthikeyan is a member of the RHD Expert panel of the Global Burden of Disease Study Group, and Chair of the Advisory Board of Rheumatic Heart Disease, Evidence, Advocacy, Communication, Hope (RhEACH). He played a central role in the design and conduct of the Rheumatic Heart Disease Global Registry (REMEDY) and is one of the key leaders of the ongoing INVICTUS trial for stroke prevention in RHD. He serves as an honorary consultant to the Human Health Division of the International Atomic Energy Agency, providing advice in identifying, designing and implementing research protocols in resource-poor settings.
Dr Azeem Latib is an interventional cardiologist at San Raffaele Hospital and EMO-GVM Centro Cuore Columbus in Milan Italy. He started his career in South Africa and obtained his specialisation in internal medicine and cardiology at Groote Schuur Hospital in the University of Cape Town where he is now honorary senior lecturer. In 2008 he obtained his masters in interventional cardiology in Milan, at San Raffaele Hospital where he is now co-director of research and structural heart disease. Azeem has dedicated his efforts in maintaining both a research and a clinical approach to interventional cardiology. He has published over 400 publications in peer-reviewed journals and books. His interests and experience include complex coronary interventions, structural heart disease and new device innovation. He is actively involved in pre-clinical animal work for coronary and structural interventions. He has also performed a number of first-in-man procedures and is principal investigator in numerous CE-mark and multi-center studies.
Dr. Mehra is a Professor of Medicine at Harvard Medical School and serves as Medical Director of the Heart and Vascular Center and Executive Director of the Center for Advanced Heart Disease at Brigham Health in Boston, Massachusetts. Additionally, he is Editor-in-Chief, The Journal of Heart and Lung Transplantation. Prior to joining Brigham and Women’s Hospital in January 2012, Dr. Mehra served as the Dr. Herbert Berger Endowed Professor of Medicine, Head of Cardiology and Assistant Dean for Clinical Services at the University of Maryland School of Medicine in Baltimore, Maryland. He is an expert in Advanced Heart Failure with special expertise in mechanical circulatory support and heart transplantation.
He has authored and published over 400 book chapters, manuscripts, editorials and abstracts focusing on all aspects of advanced heart failure. One important area of his interest is in developing international guidelines for care of the heart transplant candidate and process enhancement for improving performance measure adherence in heart failure.
Dr Carlos A. Mestres, is currently a Senior Consultant in the Department of Cardiovascular Surgery, University Hospital Zürich, Zürich (Switzerland) and has expertise in Cardiovascular and Thoracic Surgery. He received his MD in 1979 and PhD in 1988 from the University of Barcelona. He holds the Spanish Certificates in Thoracic Surgery (1982) and Cardiovascular Surgery (1988), The European Board of Thoracic, and Cardiovascular Surgery (FETCS – 1988).
He has a particular interest in inflammatory/infectious cardiovascular diseases, in addition to the regular practice in all areas of surgery (especially endocarditis and HIV-1 infection), cardiovascular tissues (homograft valve and arteries), coronary surgery, valve surgery and surgery of the aorta, biomaterials and medical devices. In addition, he has a particular interest in hospital management, databases, and quality assurance. He is active in clinical surgery.
A member of the University Hospital Zürich Endokarditis Board and the Hospital Clinic Endocarditis Working Group, the latter the pioneer in co-operative work in the field in Spain and Europe, active for over three decades, a number of studies and publications were produced over the years. Dr. Mestres has participated in the development of Cardiovascular Tissue banking in Spain, as the tissue bank at the Hospital Clinic was the first of its kind in the country and a pioneer in Europe. Currently, Dr Mestres has over 260 international publications in peer-reviewed international journals, 115 domestic publications in Spanish journals and over 30 chapters in books.
Dr Mestres is a clinical surgeon. He has participated in the teaching of surgical residents in cardiovascular surgery and has experience in academic and scientific activities. He was a member of the Spanish National Cardiovascular Council, the regulatory body for Specialty training, for ten years (1997-2006). He is currently a member of the European Board of Thoracic and Cardiovascular Surgeons (EBTCS).
He serves in the Editorial Board of several Journals: Past Editor-in-Chief, Cirugia Cardiovascular, Official Journal of the Spanish Society for Thoracic-Cardiovascular Surgery (SECTCV) 2004-2012, Associate Editor The European Journal of Cardio-Thoracic Surgery (2012-2017), Associate Editor - Asian Cardiovascular and Thoracic Annals (2005). He also serves as an Editorial Board Member - The Journal of Thoracic and Cardiovascular Surgery (2013-2020), The European Journal of Cardio-thoracic Surgery (EJCTS)
Dr Mestres is currently the Director of the Teaching Programme of the CAS-Certificate of Advanced Studies in Structural Cardiac Interventions (www.structuralinterventions.ch) issued by the University of Zürich.
Dr. Philip Moons is Professor of Healthcare and Nursing Science at the Academic Center for Nursing and Midwifery at the KU Leuven - University of Leuven, Belgium, and visiting professor at the Institute of Health and Care Sciences of the University of Gothenburg, Sweden. Currently, he is program director for the Master in Nursing and Midwifery of the KU Leuven - University of Leuven.
Philip Moons has published more than 250 articles in international, peer-reviewed journals; and presented over 280 abstracts at national and international conferences. He is mainly involved in outcome and quality of life research in congenital heart disease, and developed and implemented the role of advanced practice nurse in the Adult Congenital Heart Disease Program of the University Hospitals of Leuven. Furthermore, he co-ordinated large-scale implementation projects on discharge management. The spearhead of Philip Moons' research is ‘Transition and Care’.
For his work, Philip Moons received Martha N. Hill New Investigators Award 2004 from the American Heart Association and the Atie Immink New Investigators Award 2008 from the European Society of Cardiology. He is fellow of the American Heart Association (FAHA) and the European Society of Cardiology (NFESC). In 2014, he was inducted as Fellow of the American Academy of Nursing (FAAN), which is a prestigious recognition for his work and his contribution to nursing.
Dr Vuyisile Nkomo is an Associate Professor of Medicine and Consultant in the Department of Cardiovascular Diseases, Mayo Clinic, and Director of the Valvular Heart Disease Clinic. His areas of interest include echocardiography and valvular heart disease epidemiology. Dr. Nkomo received his Doctor of Medicine (MD) degree from Meharry Medical College, Nashville, Tennessee, and completed Internal Medicine and Cardiology Fellowship training at Mayo Clinic, Rochester, Minnesota. He also received his Masters in Public Health (MPH) from the University of Minnesota, Twin Cities, Minnesota, as part of his Cardiology Fellowship. He is a Fellow of the American College of Cardiology (FACC) and a Fellow of the American Society of Echocardiography (FASE).
Mark Petrie is Professor of Cardiology at the University of Glasgow. He worked as a clinician with a sub-speciality interest in heart failure, advanced heart failure and interventional cardiology before accepting a formal academic role 2 years ago. He is also on the steering and executive committees of many trials (including intravenous iron, various interventional heart failure therapies, trials of coronary artery disease and HF (STICH and REVIVED) and others). He was an author of the ESC NSTEMI guidelines and a senior author of the ESC Position Statement on Diabetes and Heart Failure. He is involved in ongoing trials of diabetes therapies in cardiovascular disease and heart failure. One of his major interests is peripartum cardiomyopathy (member of the Executive Committee and Steering Group of the ESC Peripartum Cardiomyopathy Registry). Mark is the UK Lead for PARADISE-MI and Dapa-HF and has also served on the Clinical Events Committee of over 30 trials including EMPA-REG OUTCOME, TRUE-HF, ASCEND, the original HARMONY programme, CARMELINA and CAROLINA amongst many others.
Immediate Past-President of European Society of Cardiology (2016-18), Dean of the Faculty of Medicine, University of Lisbon (2015-2018), Head of Cardiology Department at Santa Maria University Hospital, CHLN, E.P.E. in Lisbon, Portugal, Head of Heart and Vessels Department, University Hospital of Santa Maria/CHLN, Lisbon, Portugal (since 2016), Full Professor of Cardiology and Chair of Cardiology Clinic at Lisbon University Medical School in Lisbon, Portugal, Director of the Lisbon Cardiovascular Institute, President of the Association for Research and Development of the Faculty of Medicine.
Dr Pislaru completed medical school at the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania, and received his PhD. from the Catholic University of Leuven in Belgium. He then continued his training at Mayo Clinic Rochester, where he completed his residency and cardiology fellowship, as part of the combined clinician-investigator track. Upon his graduation, Dr. Pislaru joined the Mayo Clinic faculty, dividing his time between the Echo Lab, Valve Clinic, and research.
He is currently an Associate Professor of Medicine, and Chair for Research in the Division of Cardiovascular Ultrasound. He directs the Echocardiography and Vascular Physiology Research Unit which affords advanced training in echocardiographic research to over 20 fellows/trainees annually. Dr. Pislaru has presented both nationally and internationally and has authored over 80 publications in peer-reviewed journals. His research interests are focused on valvular diseases, myocardial elasticity, and development and imaging guidance of percutaneous valvular interventions.
Charanjit S. Rihal, M.D., is an academic interventional cardiologist and an expert in the field of coronary and valve and structural cardiology. As the principal investigator on multiple research grants, Dr. Rihal oversees studies focusing on valvular and structural heart disease (for example, percutaneous aortic valve therapies), clinical trials in coronary artery disease, and developing novel genetic approaches to anti-thrombotic therapy. His research has been funded by the National Heart, Lung, and Blood Institute; industry sources; and Mayo Clinic, and his research findings have been published in prestigious peer-reviewed journals such as Circulation, Journal of the American College of Cardiology, American Journal of Cardiology and JACC: Cardiovascular Interventions.
As a cardiologist, Dr. Rihal specializes in interventional cardiology, with a focus on new device therapies, the treatment of valve and structural heart conditions, and acute myocardial infarction. He frequently lectures on therapies for heart disease, particularly heart valves and coronary arteries.
Dr Nadeem Rizvi is one of the top cardiologists in Pakistan. Aside from being highly qualified, the sheer volume of his work has earned him a reputation as one of the best interventional cardiologists. To date he has done more than 15,000 diagnostic cardiac catheterization procedures and 5,000 coronary interventions, over 100 Percutaneous Transvenous Mitral Commissurotomies, 150 peripheral interventions and 100 permanent pacemaker insertions.
He is certified in CT angiography (to visualize arterial and venous vessels throughout the body) from Johns Hopkins University Hospital, Baltimore, in Nuclear Cardiology from NICVD, in Coronary Angioplasty or the Percutaneous Transluminal Coronary Angioplasty (PTCA), a minimally invasive procedure to open up blocked coronary arteries, and the adult echocardiography from the British Society of Echocardiography. Part of his specialist training is in nuclear cardiology, electrophysiology, valvular, congenital and coronary interventions.
Dr Nadeem Rizvi has worked in the UK and in Pakistan. He was a clinical research fellow in cardiology and honorary registrar at Ealing and Hammersmith Hospitals Trusts, London. He was involved in a large research project titled, “Premature coronary arterial disease in British Asians” at Ealing Hospital. He has worked as a consultant cardiologist at Barnsley District Hospital, and he trained at the East Cheshire Hospitals Trust, Macclesfield, UK in non-invasive and invasive (pacemaker implantation and right heart studies) implantation, cardiac biopsies and interventional coronary procedures.
He is a member of the British Society of Echocardiography, a founding member of the Pakistan Society of interventional Cardiology, a member of the Pakistan Cardiac Society, a member of the Civil Aviation Medical Board and an examiner for the College of Physicians and Surgeons of Pakistan. He has been the editor of the Pakistan Heart Journal’s interventional section since 2012. He has taught, lectured and been an examiner for post-graduate trainees and residents. He has supervised the non-invasive cardiac lab (ECG, ETT, Holter, Transthoracic and Trans-esophageal echocardiography).
Lars Georg Svensson is the Chairman of the Sydell and Arnold Miller Family Heart and Vascular Institute as well as Staff Surgeon in the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic. He is also Professor of Surgery at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Svensson is board-certified in general, vascular, thoracic and cardiac surgery. He specialises in aortic valve surgery, aortic valve and bicuspid valve repair, cardiac surgery, complex aortic aneurysm, endovascular aorta treatment, heart surgery of patients with Marfan Syndrome, modified David’s reimplantation procedure, percutaneous treatment of patients with valve disease, minimally invasive heart surgery, Marfan syndrome and connective tissue disorders. He obtained his medical degree in 1978, a MSc in 1983 and a PhD in 1986 from the University of Witwatersrand, Johannesburg, South Africa. He completed his Cardiology, General and Vascular Surgery training at the Johannesburg Hospital, followed by Cardiovascular Surgery training at the Cleveland Clinic (Cleveland, Ohio), and Baylor College of Medicine (Houston, TX) including Cardiothoracic Surgery residency. He was Chief of Cardiovascular Surgery at Houston Veterans Affairs Medical Center and worked with Drs. DeBakey and Crawford at Baylor College of Medicine. He was Assistant Professor of Surgery at Baylor College of Medicine, and then Professor of Cardiothoracic Surgery at Tufts University, and Instructor at Harvard Medical School while working at the Lahey Hospital and Medical Center in Boston. In 2005 he was made King James IV Professor of Surgery of The Royal College of Surgeons of Edinburgh, Scotland. He is on numerous committees, including the Society of Thoracic Surgery, American Association for Thoracic Surgery Government Relations Committee, Annals of Thoracic Surgery, and the Cleveland Clinic Surgery Committee. His interests are minimal invasive valve surgery, percutaneous cardiovascular surgery, and brain and spinal cord protection during cardiovascular surgery.
William Wijns, MD, PhD, FESC, is SFI Professor in Interventional Cardiology at NUI Galway since September 2016. Research efforts are targeting the development and validation of innovative techniques in interventional medicine including invasive and non-invasive physiological measurements and imaging, drug-eluting stents, and applications of multi-detector coronary CT angiography.
In addition, ongoing research aims to prevent high-risk subjects from suffering cardiac disability by modification of vulnerable plaques and modulation of trigger mechanisms that precipitate acute events.
Professor Wijns is committed to the development and evaluation of novel device-based therapies of cardiovascular diseases.
Wijns served the European Society of Cardiology (ESC) in various positions, including Vice-President, Chairman of EU Affairs, Scientific Program Chair and President of the European Association of Percutaneous Cardiac Intervention (EAPCI) of the ESC. Presently, he chairs PCR with focus on adult learning, knowledge transfer techniques and education science via Courses and other educational activities (publishing, web-based learning, seminars, and workshops).
Professor Wijns is Associate Editor of the European Heart Journal, covering acute coronary syndromes, coronary artery disease, and interventional cardiology.